Full text is available at the source.
Abstract
Endoscopic bariatric therapies may offer potential cost-effective alternatives to traditional bariatric surgery and medication.
- This evaluation focuses on endoscopic sleeve gastroplasty (ESG) and intragastric balloon (IGB).
- Cost-effectiveness was analyzed from the perspective of the UK health system.
- Economic value relative to established treatments, such as bariatric surgery and semaglutide, is currently uncertain.
Simplified